Hepatoma: Clinical Trials

2 trials for Hepatoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 22Unknown 2

Follow Hepatoma: new trials by email Literature Review of Hepatoma trials Research Report on Hepatoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
CAR-T/TCR-T cells immunotherapy - Esophagus Cancer, Hepatoma
Phase 1 / Phase 2UnknownShenzhen BinDeBio Ltd.502019-09-012021-02-04
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
CAR-T cell immunotherapy - B-cell Acute Lymphoblastic Leukemia, Lymphoma
Phase 1 / Phase 2UnknownShenzhen BinDeBio Ltd.732018-03-012019-12-11

Narrower conditions

Carcinoma, Hepatocellular (2)  ·  Esophageal Neoplasms (2)  ·  Glioma (2)  ·  Stomach Neoplasms (2)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Leukemia, Myeloid (1)  ·  Lung Neoplasms (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Mesothelioma (1)  ·  Multiple Myeloma (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Esophageal Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Liver Diseases (2)  ·  Liver Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)

Interventions

Immunotherapy, Adoptive (1)

Sponsors

Shenzhen BinDeBio Ltd. (2)

Countries

China (2)